Cogent Biosciences, Inc. Common Stock (COGT)

Cogent Biosciences (COGT) sees significant social media buzz with sentiment up over 200% this week, driven by FDA designations and positive trial data, despite market volatility and high short interest.

About Cogent Biosciences, Inc. Common Stock

Cogent Biosciences, Inc. Common Stock (COGT) is a biotechnology company focused on developing therapies for cancer and inflammatory diseases.
Cogent Biosciences, Inc. Common Stock uses the ticker $COGT for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Cogent Biosciences, Inc. Common Stock (COGT) social dominance is up 67% from the previous week.
Cogent Biosciences, Inc. Common Stock (COGT) Galaxy Score™ is up 65.63% from the previous [--] months.
Cogent Biosciences, Inc. Common Stock (COGT) sentiment is up 203.03% from the previous week.
Cogent Biosciences, Inc. Common Stock (COGT) creators is up 33.82% from the previous week.
Cogent Biosciences, Inc. Common Stock (COGT) engagements is up 42.92% from the previous week.
Cogent Biosciences, Inc. Common Stock (COGT) mentions is up 41.09% from the previous week.
Cogent Biosciences, Inc. Common Stock (COGT) posts created is up 57.14% from the previous week.

Price: $36.50

Price 24-Hour Time-Series Raw Data
The stock price is facing headwinds due to market volatility and significant short interest, despite positive clinical trial data and FDA designations. Recent social posts highlight potential M&A activity and strong analyst ratings, which may be counteracting some of the negative price pressures.

24-Hour: -0.84% 7-Day: 0.38% 30-Day: -6.19%

1-Year High: $42.10 on 2025-12-12
1-Year Low: $4 on 2025-04-10

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Cogent Biosciences, Inc. Common Stock (COGT) is currently AltRank #777 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] [----]
[--] Months: [---] +128
[--] Year: [---] +445
1-Year High: [-----] on 2026-02-11
1-Year Low: [--] on 2025-12-06

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +6
[--] Month: [--] +15
1-Year High: [--] on 2025-12-08
1-Year Low: [--] on 2025-12-26

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] +43%
[--] Month: [-------] -74%
[--] Months: [---------] +66%
[--] Year: [---------] +247%
1-Year High: [-------] on 2025-07-07
1-Year Low: [---] on 2025-09-07

Engagements by network (24h): YouTube: [--] X: [-----] Reddit: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +41%
[--] Month: [---] +21%
[--] Months: [-----] -47%
[--] Year: [-----] +1,520%
1-Year High: [-----] on 2025-07-08
1-Year Low: [--] on 2025-04-23

Mentions by network (24h): YouTube: [--] X: [--] Reddit: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Cogent Biosciences, Inc. Common Stock (COGT) in the last [--] hours which is down 21% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +34%
[--] Month: [---] +19%
[--] Months: [-----] -67%
[--] Year: [-----] +2,205%
1-Year High: [-----] on 2025-07-08
1-Year Low: [--] on 2025-04-23

The most influential creators that mention Cogent Biosciences, Inc. Common Stock in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@seedy19tron	[--]	[------]	[--]	[---]
@Biotech2k1	[--]	[------]	[--]	[---]
@CharlieQuiTrade	[--]	[--]	[--]	[---]
@Stock_Analysis2	[--]	[---]	[--]	[--]
@BiopharmIQ	[--]	[------]	[--]	[--]
@Trade_market1	[--]	[---]	[--]	[--]
@Stock_Marketr13	[--]	[---]	[--]	[--]
@Stock_Marketr11	[--]	[---]	[--]	[--]
@Trade_market6	[--]	[---]	[--]	[--]
@hg19290	[--]	[--]	[--]	[--]

Sentiment: 30%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 30%
Daily Average: 78%
[--] Week: 100% +67%
[--] Month: 24% -51%
[--] Months: 24% -72%
[--] Year: 24% -76%
1-Year High: 100% on 2025-02-17
1-Year Low: 22% on 2025-04-20

Most Supportive Themes:

FDA Breakthrough Therapy Designation: (30%) Cogent Biosciences received FDA Breakthrough Therapy Designation for bezuclastinib in Non-Advanced Systemic Mastocytosis.
Positive Clinical Trial Data: (25%) Upcoming trial readouts (PEAK and APEX) for bezuclastinib are anticipated in Q4 2025, with topline Phase [--] data expected in November [----].
Analyst Ratings and Price Targets: (20%) Raymond James reiterated a Strong Buy rating with a $30 price target, and Guggenheim raised their price target to $20 from $17, reiterating a Buy rating.

Most Critical Themes:

Market Volatility and Mixed Signals: (40%) Despite positive developments, the overall market is experiencing volatility, creating mixed signals for COGT.
Short Interest: (35%) The stock has a notable short ratio of [----] and a short float of 15.11%, indicating significant short pressure.

Social Dominance: 0.00603%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00603%
Daily Average: 0.012%
[--] Week: 0.00668% +0.00268%
[--] Month: 0.012% +0.0034%
[--] Months: 0.012% +0.0058%
[--] Year: 0.012% +0.0075%
1-Year High: 0.275% on 2025-07-08
1-Year Low: 0.0012% on 2025-09-22

Market Dominance: 0.00635%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00635%
Daily Average: 0%
1-Year High: 0.263% on 2026-02-06
1-Year Low: 0.00635% on 2026-02-16

Market Cap: $5,607,558,180

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $5,607,558,180
Daily Average: $5,529,873,160
[--] Week: $5,641,329,404 -2.60%
[--] Month: $5,607,558,180 -6.20%
1-Year High: $6,464,119,216 on 2025-12-12
1-Year Low: $2,169,033,591 on 2025-11-04

Top Cogent Biosciences, Inc. Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"🔎Ma watchlist d'Action US pour cette semaine : $ACDC $ALMS $AUGO $AXGN $AXSM $BIOA $BLNE $CELC $CIFR $COGT $CTMX $ELVN $FTAI $GGAL $GRAL $GSAT $IBRX $IMVT $IRWD $MIRM $MU $NESR $NSSC $PANL $PGEN $PLAB $RLAY $SATS $SGML $SKYT $SLS $SNDX $SRRK $STX $TERN la suite en com"
X Link @CharlieQuiTrade 2026-02-15T18:06Z [--] followers, [---] engagements

"DEEP TRACK UPDATES 13F $XBI $IBB NEW POSITIONS: $VERA $GRAL $MLTX $ALKS $CNTA $SLNO $VSTM $ENTA $ATAI $COGT $NMPR $BLLN $IVA $JANX $ANL INCREASED $IMVT $TARS $AXSM $PCVX $MAZE $BMRN $NRIX $MBX $IMCR $CRMD $DYN $BCAX $ENGN $ANIP $DFTX $TNGX $XFOR $HELP"
X Link @BOSSTRADING0 2026-02-14T16:40Z [----] followers, [----] engagements

"The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt Feels like forever since the last weekly but nice to get back to work. The past week felt like a movie but important to not get distracted. Long weekend ahead with markets being closed on Monday so will use this time to get back up to speed and work on a few new ideas. $iron CRL ngl was a surprise but Im glad I passed on it even though there were rumours that approval was a foregone conclusion. $goss and $ocul should be"
X Link @seedy19tron 2026-02-13T20:34Z 14.2K followers, 15.7K engagements

"Here is my Biotech for this week. I added to $INSM $BBIO $PTGX $IDYA $PRAX and $COGT yesterday. I also added trading positions with $IMNM $APGE and $XENE. That way I have stuff to sell for profits when the bubble continues"
X Link @Biotech2k1 2026-02-06T22:53Z 34.2K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing